Biopharmaceutical revenue - statutory health insurance market Germany 2014

This statistic shows a distribution of revenues of biopharmaceuticals on the statutory health insurance market in Germany as of 2014, by patent status. That year, the revenue generated by biosimilars at pharmacy retail prices on the statutory health insurance market amounted to roughly 100 million euros.

Distribution of revenues on the statutory health insurance market of biopharmaceuticals in Germany as of 2014, by patent status

Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

April 2015

Region

Germany

Survey time period

2014

Supplementary notes

* Considering all discounts.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Biotechnology in Germany"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.